Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 35 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Brunnenberg, M; Kovar, KA
      Stereospecific analysis of ecstasy-like N-ethyl-3,4-ethylenedioxyamphetamine and its metabolites in humans

      JOURNAL OF CHROMATOGRAPHY B
    2. Zhao, HR; Brenneisen, R; Scholer, A; McNally, AJ; ElSohly, MA; Murphy, TP; Salamone, SJ
      Profiles of urine samples taken from ecstasy users at rave parties: Analysis by immunoassays, HPLC, and GC-MS

      JOURNAL OF ANALYTICAL TOXICOLOGY
    3. Spitzer, M; Franke, B; Walter, H; Buechler, J; Wunderlich, AP; Schwab, M; Kovar, KA; Hermle, L; Gron, G
      Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans

      NEUROPHARMACOLOGY
    4. Riba, J; Rodriguez-Fornells, A; Urbano, G; Morte, A; Antonijoan, R; Montero, M; Callaway, JC; Barbanoj, MJ
      Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

      PSYCHOPHARMACOLOGY
    5. Buchler, J; Maichle-Mossmer, C; Kovar, KA
      Enantioselective production and crystal structure of the ecstasy analogue N-ethyl-3,4-methylenedioxyamphetamine-HCl (MDE) and its major metabolites MDA and HME

      ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES
    6. Kreth, KP; Kovar, KA; Schwab, M; Zanger, UM
      Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs

      BIOCHEMICAL PHARMACOLOGY
    7. Lester, SJ; Baggott, M; Welm, S; Schiller, NB; Jones, RT; Foster, E; Mendelson, J
      Cardiovascular effects of 3,4-methylenedioxymethamphetamine - A double-blind, placebo-controlled trial

      ANNALS OF INTERNAL MEDICINE
    8. Carr-Locke, DL
      Mucin hypersecreting neoplasms

      ANNALS OF ONCOLOGY
    9. Vollenweider, FX; Gamma, A; Liechti, M; Huber, T
      Is a single dose of MDMA harmless?

      NEUROPSYCHOPHARMACOLOGY
    10. Gouzoulis-Mayfrank, E; Schreckenberger, M; Sabri, O; Arning, C; Thelen, B; Spitzer, M; Kovar, KA; Hermle, L; Bull, U; Sass, H
      Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers - A double-blind, placebo-controlled PET study with [F-18]FDG

      NEUROPSYCHOPHARMACOLOGY
    11. Gouzoulis-Mayfrank, E; Hermle, L; Kovar, KA; Sass, H
      R. Thomasius, M. Schmolke, D. Kaus: Usage of MDMA (Ecstasy) - Psychiatric and medical consequences. Fortschr. Neurol. Psychiat. 65 (1997) 49-61

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    12. Sondermann, N; Kovar, KA
      Screening experiments of ecstasy street samples using near infrared spectroscopy

      FORENSIC SCIENCE INTERNATIONAL
    13. Sondermann, N; Kovar, KA
      Identification of ecstasy in complex matrices using near-infrared spectroscopy

      FORENSIC SCIENCE INTERNATIONAL
    14. Hegadoren, KM; Baker, GB; Bourin, M
      3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    15. Hensley, D; Cody, JT
      Simultaneous determination of amphetamine, methamphetamine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and methylenedioxyethylamphetamine (MDEA) enantiomers by GC-MS

      JOURNAL OF ANALYTICAL TOXICOLOGY
    16. Gouzoulis-Mayfrank, E; Thelen, B; Habermeyer, E; Kunert, HJ; Kovar, KA; Lindenblatt, H; Hermle, L; Spitzer, M; Sass, H
      Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers - Results of an experimental double blind placebo controlled study

      PSYCHOPHARMACOLOGY
    17. VOLLENWEIDER FX; GAMMA AG; LIECHTI M; HUBER T
      PSYCHOLOGICAL AND CARDIOVASCULAR EFFECTS AND SHORT-TERM SEQUELAE OF MDMA (ECSTASY) IN MDMA-NAIVE HEALTHY-VOLUNTEERS

      Neuropsychopharmacology
    18. GOLDBERG IS
      VERTICAL MIGRATION OF ELEMENTS FROM MINERAL-DEPOSITS

      Journal of geochemical exploration
    19. GOUZOULISMAYFRANK E; HERMLE L; THELEN B; SASS H
      HISTORY, RATIONALE AND POTENTIAL OF HUMAN EXPERIMENTAL HALLUCINOGENICDRUG RESEARCH IN PSYCHIATRY

      Pharmacopsychiatry
    20. HERMLE L; GOUZOULISMAYFRANK E; SPITZER M
      BLOOD-FLOW AND CEREBRAL LATERALITY IN THE MESCALINE MODEL OF PSYCHOSIS

      Pharmacopsychiatry
    21. Judd, LL; Akiskal, HS; Maser, JD; Zeller, PJ; Endicott, J; Coryell, W; Paulus, MP; Kunovac, JL; Leon, AC; Mueller, TI; Rice, JA; Keller, MB
      Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse

      JOURNAL OF AFFECTIVE DISORDERS
    22. SCHECHTER MD
      MDMA-LIKE STIMULUS EFFECTS OF HALLUCINOGENS IN MALE FAWN-HOODED RATS

      Pharmacology, biochemistry and behavior
    23. VUILLEMET F; WARTER JM
      CHRONICLE OF AN ARTIFICIAL PARADISE, OR O NCE UPON A TIME, ADAM AND EVE

      La Semaine des hopitaux de Paris
    24. EFFENBERGER F; JAGER J
      STEREOSELECTIVE SYNTHESIS OF (S)-3,4-METHYLENEDIOXYAMPHETAMINES FROM (R)-CYANOHYDRINS

      Chemistry
    25. ROTHE M; PRAGST F; SPIEGEL K; HARRACH T; FISCHER K; KUNKEL J
      HAIR CONCENTRATIONS AND SELF-REPORTED ABUSE HISTORY OF 20 AMPHETAMINEAND ECSTASY USERS

      Forensic science international
    26. TROUTT MD; RAI A; TADISINA SK
      AGGREGATING MULTIPLE EXPERT DATA FOR LINEAR CASE VALUATION MODELS USING THE MDE PRINCIPLE

      Decision support systems
    27. FROST M; KOHLER H; BLASCHKE G
      ANALYSIS OF ECSTASY BY CAPILLARY ELECTROPHORESIS

      International journal of legal medicine
    28. HERMLE L; GOUZOULISMAYFRANK E; SPITZER M
      HALLUCINOGEN-INDUCED DISORDERS

      Fortschritte der Neurologie, Psychiatrie
    29. ENSSLIN HK; MAURER HH; GOUZOULIS E; HERMLE L; KOVAR KA
      METABOLISM OF RACEMIC 3,4-METHYLENEDIOXYETHYLAMPHETAMINE IN HUMANS - ISOLATION, IDENTIFICATION, QUANTIFICATION, AND SYNTHESIS OF URINARY METABOLITES

      Drug metabolism and disposition
    30. BALANZO X; RAFEL J; DELATORRE R; CAMI J
      ACUTE FATAL POISONING BY METHYLENEDIOXYAM PHETAMINE

      Medicina Clinica
    31. HEGADOREN KM; MARTINIVERSON MT; BAKER GB
      COMPARATIVE BEHAVIORAL AND NEUROCHEMICAL STUDIES WITH A PSYCHOMOTOR STIMULANT, AN HALLUCINOGEN AND 3,4-METHYLENEDIOXY ANALOGS OF AMPHETAMINE

      Psychopharmacology
    32. GOUZOULIS E; VONBARDELEBEN U; RUPP A; KOVAR KA; HERMLE L
      NEUROENDOCRINE AND CARDIOVASCULAR EFFECTS OF MDE IN HEALTHY-VOLUNTEERS

      Neuropsychopharmacology
    33. MICHEL RE; REGE AB; GEORGE WJ
      HIGH-PRESSURE LIQUID CHROMATOGRAPHY ELECTROCHEMICAL DETECTION METHOD FOR MONITORING MDA AND MDMA IN WHOLE-BLOOD AND OTHER BIOLOGICAL TISSUES/

      Journal of neuroscience methods
    34. HERMLE L; GOUZOULIS E; OEPEN G; SPITZER M; KOVAR KA; BORCHARDT D; FUNFGELD M; BERGER M
      THE SIGNIFICANCE OF HALLUCINOGENIC RESEAR CH IN PSYCHIATRY - HISTORY AND PRESENT STATUS

      Nervenarzt
    35. ELAYAN I; GIBB JW; HANSON GR; LIM HK; FOLTZ RL; JOHNSON M
      SHORT-TERM EFFECTS OF 2,4,5-TRIHYDROXYAMPHETAMINE, 2,4,5-TRIHYDROXYMETHAMPHETAMINE AND 3,4-DIHYDROXYMETHAMPHETAMINE ON CENTRAL TRYPTOPHAN-HYDROXYLASE ACTIVITY

      The Journal of pharmacology and experimental therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/05/20 alle ore 21:50:13